What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
The scientist’s investigation covers issues in Pathology, Cancer research, Internal medicine, Cancer and Breast cancer.
Jahn M. Nesland interconnects Cell and Melanoma in the investigation of issues within Pathology.
His Cancer research research integrates issues from Cell culture, Cancer stem cell, Molecular biology and Cell cycle, Gene.
The Internal medicine study combines topics in areas such as Gastroenterology, Endocrinology and Oncology.
His research investigates the link between Breast cancer and topics such as Survival rate that cross with problems in Adenocarcinoma.
The study incorporates disciplines such as Ovarian carcinoma, Breast carcinoma and Survival analysis in addition to Carcinoma.
His most cited work include:
- DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis (2235 citations)
- 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. (875 citations)
- 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research (512 citations)
What are the main themes of his work throughout his whole career to date?
Jahn M. Nesland mainly focuses on Pathology, Internal medicine, Cancer research, Immunohistochemistry and Oncology.
His studies deal with areas such as Ovarian carcinoma and Cancer, Metastasis as well as Pathology.
In his research on the topic of Cancer, Hexaminolevulinate and Molecular biology is strongly related with Apoptosis.
His Cancer research study combines topics from a wide range of disciplines, such as Cell, Cell cycle, Carcinogenesis, Tumor suppressor gene and Cancer stem cell.
His Immunohistochemistry study integrates concerns from other disciplines, such as Ovary, Stromal cell, Lymph node and Adenocarcinoma.
His Oncology research includes elements of Cancer registry, Radiation therapy, Chemotherapy and Univariate analysis.
He most often published in these fields:
- Pathology (61.55%)
- Internal medicine (39.71%)
- Cancer research (33.40%)
What were the highlights of his more recent work (between 2012-2021)?
- Internal medicine (39.71%)
- Oncology (31.30%)
- Pathology (61.55%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Pathology, Cancer research and Cancer.
His Internal medicine research includes themes of Endocrinology and Gerontology.
His biological study spans a wide range of topics, including Immunohistochemistry, Chemotherapy, Cancer registry, Stage and Cohort.
His Pathology research incorporates elements of Ovarian carcinoma, Cell and Breast cancer.
His Cancer research research includes elements of Cell growth, Cancer cell, Apoptosis, Ovarian cancer and Stem cell.
The Cancer stem cell research Jahn M. Nesland does as part of his general Cancer study is frequently linked to other disciplines of science, such as DU145, therefore creating a link between diverse domains of science.
Between 2012 and 2021, his most popular works were:
- Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer (198 citations)
- Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c (77 citations)
- Expression of SSTR2a, but not of SSTRs 1, 3, or 5 in Somatotroph Adenomas Assessed by Monoclonal Antibodies Was Reduced by Octreotide and Correlated With the Acute and Long-Term Effects of Octreotide (76 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
His main research concerns Internal medicine, Pathology, Oncology, Cancer research and Cancer.
His Internal medicine research is multidisciplinary, incorporating elements of Antibody and Monoclonal antibody.
His Pathology research is multidisciplinary, incorporating perspectives in Ovarian carcinoma, Epithelial–mesenchymal transition and Colorectal cancer.
His studies deal with areas such as Immunohistochemistry, Tissue microarray, Prostate cancer, MicroRNA 29c and Cohort as well as Oncology.
His Cancer research research incorporates themes from Cell, Cancer cell, Cancer stem cell, Stem cell and Glycolysis.
His Cancer research integrates issues from Dysgerminoma, PI3K/AKT/mTOR pathway and Everolimus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
